Switching from etravirine to doravirine in virologically suppressed people with HIV: results from the French multicentre SWEED observational study

Doravirine-based ART maintained virological suppression in PWH switching from etravirine-based ART, even in presence of prior NNRTI resistance. Its once-daily dosing, favourable safety profile, and minimal drug interactions support its use in long-term ART strategies.

Authors

Institutions

Publication Details

Journal
Journal of Antimicrobial Chemotherapy
Published
2025-10-15
DOI
https://doi.org/10.1093/jac/dkaf410
Citations
1
Primary Topic
HIV/AIDS drug development and treatment
Type
article
Field-Weighted Citation Impact
1.40
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Switching from etravirine to doravirine in virologically suppressed people with HIV: results from the French multicentre SWEED observational study

Claudine Duvivier, Christine Katlama, Clotilde Allavena, Jade Ghosn et al.
1 citations
Journal of Antimicrobial Chemotherapy
HIV/AIDS drug development and treatment
1.40
article

Switching from etravirine to doravirine in virologically suppressed people with HIV: results from the French multicentre SWEED observational study

Claudine Duvivier, Christine Katlama, Clotilde Allavena, Jade Ghosn, Yasmine Dudoit, Romain Palich, A. Kaba, Pierre Delobel, Karine Lacombe, Firouzé Bani‐Sadr, Lambert Assoumou, Pascal Puglièse, Christia Palacios, Duc Vu, Olivier Robineau, Cathia Soulié
article en
1 citations

Abstract

Doravirine-based ART maintained virological suppression in PWH switching from etravirine-based ART, even in presence of prior NNRTI resistance. Its once-daily dosing, favourable safety profile, and minimal drug interactions support its use in long-term ART strategies.

Journal of Antimicrobial ChemotherapyVol. 81(1)
Centre National de la Recherche Scientifique (FR), Inserm (FR), Délégation Paris 7 (FR), Université Fédérale de Toulouse Midi-Pyrénées (FR), Université Paris Cité (FR), Centre Hospitalier Universitaire de Nice (FR), Sorbonne Université (FR), Institut Necker Enfants Malades (FR), Assistance Publique – Hôpitaux de Paris (FR), Centre Hospitalier Universitaire de Reims (FR), Centre Hospitalier de Tourcoing (FR), Centre d'Investigation Clinique de Nantes (FR), Institut Pierre Louis d‘Épidémiologie et de Santé Publique (FR), Université de Reims Champagne-Ardenne (FR), Nantes Université (FR)
Openalex Percentile: Top 15%
HIV/AIDS drug development and treatment
1.40
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.